Back to search

Japan· JP-3999053F1023

フィルゴチニブマレイン酸塩

A filgotinib product containing フィルゴチニブマレイン酸塩, registered in Japan by ギリアド・サイエンシズ, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

On Japan’s NHI price listATC L04AF04

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフィルゴチニブマレイン酸塩ATCL04AF04REGISTER NO.JP-3999053F1023PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Filgotinib is registered in 10 of 19 countries.

Countries holding a registration under ATC L04AF04 (filgotinib), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 6 of them publish a price we can compare per daily dose

Filgotinib · ATC L04AF04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フィルゴチニブマレイン酸塩
Manufacturer
ギリアド・サイエンシズ
Country
Japan (JP)
ATC code
L04AF04
ATC class
Filgotinib
Defined daily dose
0.2 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0fe578f-0e75-43fe-8690-03e194881dde
GET /v1/drugs/f0fe578f-0e75-43fe-8690-03e194881dde?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "100mg1錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3999053F1023",
  "category": "内用薬",
  "price_yen": 2109.5,
  "generic_name": "フィルゴチニブマレイン酸塩",
  "product_name_jp": null,
  "therapeutic_class": "3999",
  "transitional_expiry": null
}

See everything about filgotinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.